Human fecal matter
PreclinicalBiologic
Human fecal matter is one of 3 biologic programs targeting Fecal Microbiota Transplantation. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Fecal Microbiota Transplantation
#DrugCompanyPhaseTrials
1Tecentriq
RochePhase 2
Rifaximin、lactulose
AAir Force Military Medical University, China
Phase 2
Human fecal matter
EEnglewood Hospital and Medical Center
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Human fecal matter. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details